PRIMARY STUDY
Emerging Therapeutic Modalities and Pharmacotherapies in Neuropathic Pain Management: A Systematic Review and Meta-Analysis of Parallel Randomized Controlled Trials
Key Findings: This systematic review and meta-analysis included only randomized controlled trials. Results found that device-based interventions were more effective in reducing pain scores than the control interventions in reducing neuropathic pain intensity. The drugs searched included EMA401, capsaicin 8% patch, and Sativex, and the novel devices searched were rTMS, SCS, and TENS.
Type of Study: Clinical Meta-analysis
Study Sample Size: 4251
Study Result: Positive
Research Location(s): Austria, Canada, Egypt, Ghana, Latvia, Nigeria, Pakistan, Sudan, United Kingdom, United States
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Pharma THC
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype I
Citation: Kontor EK, Wellan C, Maaz HM, Muhammad DG, Al-Qiami A, Sharifan A, Kumah J, Lacey H, Siddiq A, Jain N. Emerging Therapeutic Modalities and Pharmacotherapies in Neuropathic Pain Management: A Systematic Review and Meta-Analysis of Parallel Randomized Controlled Trials. Pain Res Manag. 2024 Dec 26;2024:6782574. doi: 10.1155/prm/6782574. PMID: 39748928; PMCID: PMC11695085.
